Galanin within the normal and hyperplastic anterior pituitary gland: localization, secretion, and functional analysis in normal and human growth hormone-releasing hormone transgenic mice.
Studies evaluating estrogen-induced anterior pituitary tumors revealed a strong direct correlation between expression of the peptide galanin and tumor growth. To evaluate further the potential roles of galanin in the hyperplastic pituitary, we used a model of estrogen-independent anterior pituitary tumor formation, the male human GH-releasing hormone (hGHRH) transgenic mouse. Pituitaries of hGHRH transgenic mice are characterized by a hyperplasia of somatotrophs and contain markedly elevated levels of galanin. We examined the population of galanin-producing pituitary cells in 4- to 6-month-old male hGHRH transgenic mice and their nontransgenic siblings. The percentage of galanin-containing pituitary cells was significantly increased within the anterior pituitaries of hGHRH transgenic mice. By using the cell immunoblot assay we found that the basal secretion of galanin and GH from individual pituitary cells of hGHRH transgenic mice was significantly greater than that from pituitary cells of nontransgenic mice. By modifying the cell immunoblot assay, we determined that somatotrophs from both hGHRH transgenic and normal mice that were positive for galanin immunoreactivity secreted significantly greater amounts of GH than those somatotrophs devoid of galanin immunoreactivity. Moreover, immunoneutralization of galanin significantly decreased GH secretion from pituitary cells obtained from hGHRH transgenic mice. Thus, we now show that the increased levels of galanin peptide within the hyperplastic pituitaries of hGHRH transgenic mice are due to an increase in the population of cells containing galanin, and that galanin participates in the augmented secretion of GH from hyperplastic proliferating pituitary cells.
Moore
J P
JP
Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington 40536-0084, USA.
Cai
A
A
Maley
B E
BE
Jennes
L
L
Hyde
J F
JF
D000818:Animals; D002452:Cell Count; D004298:Dopamine / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D019004:Galanin / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015870:Gene Expression; D013006:Growth Hormone / Q000378:metabolism; D013007:Growth Hormone-Releasing Hormone / Q000235:genetics / Q000502:physiology*; D006801:Humans; D006965:Hyperplasia; D015151:Immunoblotting; D007700:Kinetics; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D010903:Pituitary Gland, Anterior / Q000737:chemistry* / Q000378:metabolism / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide / Q000235:genetics
D012333:RNA, Messenger; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide; D004958:Estradiol; D019004:Galanin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D004298:Dopamine